Oct 6 (Reuters) – Becton Dickinson plans to invest $19 billion in the US over several years, including $3 billion to expand domestic manufacturing, as part of an agreement with the government to strengthen the supply of essential medical products.
The medical technology company on Tuesday said the overall commitment covers capital, operational and supply-chain investments, with the $3 billion earmarked for strategic manufacturing sites across the country.
The agreement provides the company relief from future tariffs imposed under Section 232 on covered products and inputs, subject to the final scope of any tariff measures and its meeting of agreed milestones.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
Comments